At the checkpoint: Lung CD8+ T cells, respiratory viruses, and chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 193, Issue 6, 2016, Pages 600-602

  Curtis, Jeffrey L ^a,b  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRAMMED DEATH 1 RECEPTOR;

AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; EDITORIAL; HOST RESISTANCE; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLUENZA A; INFLUENZA A VIRUS (H3N2); NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY VIRUS; BACTERIAL SUPERINFECTION; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; IMMUNOCOMPETENT CELL; INFLUENZA; LOWER RESPIRATORY TRACT INFECTION; SMOKING CESSATION; VIRUS INFECTION; FEMALE; IMMUNOLOGY; LUNG; MALE;

CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INFLUENZA, HUMAN; LUNG; MALE; PROGRAMMED CELL DEATH 1 RECEPTOR; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84988683713     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201511-2122ED     Document Type: Editorial

References (15)

1. Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 2015;15:486-499.
2. Leigh R, Proud D. Virus-induced modulation of lower airway diseases: pathogenesis and pharmacologic approaches to treatment. Pharmacol Ther 2015;148:185-198.
3. Molyneaux PL, Mallia P, Cox MJ, Footitt J, Willis-Owen SA, Homola D, Trujillo-Torralbo MB, Elkin S, Kon OM, Cookson WO, et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;188:1224-1231.
4. Rynda-Apple A, Robinson KM, Alcorn JF. Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease. Infect Immun 2015;83:3764-3770.
5. Stämpfli MR, Anderson GP. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 2009;9:377-384.
6. Todt JC, Freeman CM, Brown JP, Sonstein J, Ames TM, McCubbrey AL, Martinez FJ, Chensue SW, Beck JM, Curtis JL. Smoking decreases the response of human lung macrophages to double-stranded RNA by reducing TLR3 expression. Respir Res 2013;14:33.
7. McKendry RT, Spalluto CM, Burke H, Nicholas B, Cellura D, Al-Shamkhani A, Staples KJ, Wilkinson TM. Dysregulation of antiviral function of CD81 T cells in the chronic obstructive pulmonary disease lung: role of the PD-1-PD-L1 axis. Am J Respir Crit Care Med 2016;193:642-651.
8. Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 2015;27:450-461.
9. Staples KJ, Nicholas B, McKendry RT, Spalluto CM, Wallington JC, Bragg CW, Robinson EC, Martin K, Djukanović R, Wilkinson TM. Viral infection of human lung macrophages increases PDL1 expression via IFNb. PLoS One 2015;10:e0121527.
10. Grumelli S, Corry DB, Song LZ, Song L, Green L, Huh J, Hacken J, Espada R, Bag R, Lewis DE, et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 2004;1:e8.
11. Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, Green L, Hacken-Bitar J, Huh J, Bakaeen F, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007;13:567-569.
12. Freeman CM, Han MK, Martinez FJ, Murray S, Liu LX, Chensue SW, Polak TJ, Sonstein J, Todt JC, Ames TM, et al. Cytotoxic potential of lung CD8(1) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15. J Immunol 2010;184:6504-6513.
13. Freeman CM, McCubbrey AL, Crudgington S, Nelson J,Martinez FJ, Han MK, Washko GR Jr, Chensue SW, Arenberg DA, Meldrum CA, et al. Basal gene expression by lung CD41 T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent. PLoS One 2014;9:e96421.
14. Xu C, Hesselbacher S, Tsai CL, Shan M, Spitz M, Scheurer M, Roberts L, Perusich S, Zarinkamar N, Coxson H, et al. Autoreactive T cells in human smokers is predictive of clinical outcome. Front Immunol 2012;3:267.
15. Haanen JB, Thienen Hv, Blank CU. Toxicity patterns with immunomodulating antibodies and their combinations. Semin Oncol 2015;42:423-428.